Skip to Main content Skip to Navigation
Journal articles

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease

Complete list of metadata

https://hal-univ-evry.archives-ouvertes.fr/hal-02178306
Contributor : Guillaume Corre Connect in order to contact the contributor
Submitted on : Tuesday, July 9, 2019 - 4:41:08 PM
Last modification on : Wednesday, November 17, 2021 - 12:33:14 PM

Links full text

Identifiers

Citation

Valentina Poletti, Fabrizia Urbinati, Sabine Charrier, Guillaume Corre, Roger Hollis, et al.. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Molecular Therapy - Methods and Clinical Development, Nature Publishing Group, 2018, 11, pp.167-179. ⟨10.1016/j.omtm.2018.10.014⟩. ⟨hal-02178306⟩

Share

Metrics

Les métriques sont temporairement indisponibles